Post Marketing Surveillance and Pharmacoepidemiology

Post Marketing Surveillance PMS and pharmacoepidemiology are essential components of drug safety monitoring and effectiveness evaluation in real world clinical settings. PMS involves the continuous monitoring of pharmaceutical products after regulatory approval to detect and assess adverse events and safety issues that may not have surfaced during pre marketing clinical trials. Pharmacoepidemiology, on the other hand, employs epidemiological methods to study the effects of drugs in large populations, utilizing real world data from various sources. This article explores the significance of PMS and pharmacoepidemiology in ensuring patient safety, highlights their mutual contributions in research, and underscores the importance of collaborative efforts between regulatory agencies, academia, and pharmaceutical companies. The challenges related to data quality, privacy, and ethical considerations are discussed, along with potential advancements in methodologies and the integration of new technologies for future research and vigilance in drug safety and public health. Dr. Farheen Yousuf "Post-Marketing Surveillance and Pharmacoepidemiology" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-7 | Issue-4, August 2023, URL: https://www.ijtsrd.com/papers/ijtsrd59690.pdf Paper Url:https://www.ijtsrd.com/pharmacy/other/59690/postmarketing-surveillance-and-pharmacoepidemiology/dr-farheen-yousuf